ZNTL · Zentalis Pharmaceuticals, Inc.
Market Cap
$285.97M
Shares
71.67M
Debt Profile
Annual debt figures are established from 10-K filings and updated by subsequent 10-Q and 8-K disclosures. Instrument balances are not summed into a company total unless the filing itself reports that total.
Debt data is being processed. Please check back later.
Key facts
CIK
1725160
CUSIP
98943L107
13F (30d)
85 filings
85 filers
Visit website
Investor relations